Navigation Links
Mount Sinai Experts Share Tips for Ovarian Cancer Awareness Month in September
Date:8/29/2013

New York, New York (PRWEB) August 30, 2013

Ovarian cancer is the fourth leading cause of death in American women. Approximately 22,000 women are diagnosed annually and 14,000 die from the disease. September is Ovarian Cancer Awareness month and Mount Sinai experts are sharing tips on prevention.

Expert Available for Interview
David A. Fishman, MD, Professor and Fellowship Director in the Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine is available for media interviews. Dr. Fishman is Director of the National Ovarian Cancer Early Detection Program at The Mount Sinai Medical Center.

The most important tip is to determine whether or not you have a family history of ovarian cancer, and, if you do, to consider genetic testing and possibly surgery. Because there is no effective surveillance technique for the detection of early stage ovarian cancer, genetic testing and surgery can be life-saving, according to Dr. David Fishman. “For women who have tested positive for a BRCA mutation, who are at risk for developing ovarian cancer, one option is prophylactic surgery, in which the ovaries and fallopian tubes are removed, to prevent developing ovarian cancer,” he says. “A formal genetic evaluation by a board-certified genetic counselor or geneticist is recommended for any individual (male or female) who has a family history of relatives with breast or ovarian cancer.”

Facts About Ovarian Cancer

  • Approximately 75 percent of women with ovarian cancer are diagnosed with late stage disease and only 15-40 percent of diagnosed patients survive five years after initial aggressive cytoreductive surgery and years of multiagent chemotherapy.
  • Almost 90 percent of women diagnosed with the disease confined to the ovary (stage I), have an overall five-year survival. They also require less surgical intervention, may not require chemotherapy and have a significantly improved quality of life.

Tips for Ovarian Cancer Prevention

  • Family history can be important: At least 10 percent of ovarian cancers are attributed to the inheritance of gene mutations (such as BRCA, HNPCC) which can be associated with other cancers (breast, colon, endometrial, thyroid and melanoma).
  • Take oral contraceptives: Long term use of oral contraceptives reduces the risk of developing ovarian cancer.
  • Follow a healthy diet: Eat a diet rich in whole grains, fruits and vegetables; limit intake of red or processed meat; and limit alcohol intake.
  • Pay attention to symptoms: Swollen or bloated abdomen; pressure or pain in abdomen, pelvis, back or legs; difficulty eating or feeling full quickly; nausea, indigestion, gas constipation or diarrhea; feel tired; urinary symptoms; and unusual vaginal bleeding.

Mount Sinai’s National Ovarian Cancer Early Detection Program (NOCEDP) offers high-risk individuals formal genetic evaluation (including BRCA analysis), three-dimensional sonography, experimental serum tests, and physical examination every six months. To learn more, visit http://www.mountsinai.org/patient-care/service-areas/obgyn-and-reproductive-services/research/national-ovarian-cancer-early-detection-program and also http://youtu.be/InQcgH6jGKA.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11072181.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Researchers from Mount Sinai receive NIH grant to study promising treatment for Autism subtype
2. Music for Relaxation
3. “Sculptations” Helps People Create Enormous Amounts of Money to Live a Life of Comfort and Happiness – V kool
4. Mount Sinai and Exosome Partner to Accelerate Translation of Body Fluid Molecular Diagnostics to Overcome Limitations of Tissue Biopsy in Areas of Unmet Medical Needs
5. Amerinet and NML Collaborate with Intermountain Healthcare on Integrated Supply Chain Center
6. Biomet Hip Lawsuits Mount, as Claims in Federal Litigation Approach 600, Bernstein Liebhard LLP Reports
7. Avenidas Offers New Caregiver Series for Aging Adults in Mountain View, CA
8. Da Vinci Robot Lawsuit News: Da Vinci Robot Lawsuits Mount, as Alonso Krangle LLP Continues its Investigation of Alleged Da Vinci Complications
9. Digifit Introduces The Saddle, an Innovative Forearm Mount for Exercising with an iPhone
10. Helmet-Mounted Device Helps Identify Players Who Need to be Evaluated for Concussion
11. Feelings for fetus may vary smoking amount
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... ... Foundation, the national charitable foundation serving the footwear industry, has broken all previous ... more than 130 companies across 23 states during the months of April and ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Awakening , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress ... Onnit brain and mood optimization products to the store is just one more ...
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... and author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related ... 2016 and podcasted thereafter . Dr. Bernie Siegel, author of a plethora ...
(Date:4/29/2016)... STAMFORD, CONNECTICUT (PRWEB) , ... April 29, 2016 , ... ... 5K Run/Walk” at Cove Island Park on Sunday, with sunny skies, a light breeze ... event, raising nearly $33,000. , The 5k Run and Walk and 1-mile ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... April 27, 2016   ... Growth in Recurring Consumable Sales  Clinical sales ... Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, ... sales for the first quarter ended March 31, 2016 ... execution of its commercial strategy. First Quarter ...
Breaking Medicine Technology: